Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients.
Next Steps in Derm‘s most recent installment of Therapeutic Cheat Sheet series covers everything you need to know to start and monitor your patients on IL-17 blocking therapies.
Get more from the JDD - Subscribe today!
You May Also Like
Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training
Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training
Lab to Label training boosts dermatology resident confidence in OTC product counseling Have you read this article from the upcoming April issue of JDD? An IRB approved study assessed topical…
Enhancing Patient Privacy in Dermatology: Best Practices for Image Organization and Security
Enhancing Patient Privacy in Dermatology: Best Practices for Image Organization and Security
Practical imaging security for dermatologists: encryption, secure storage, metadata hygiene and device protocols In this Letter to the Editor published in the February issue of the Journal of Drugs in…
Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis
Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…
